Aliases & Classifications for Newcastle Disease

Aliases & Descriptions for Newcastle Disease:

Name: Newcastle Disease 12 52 42 14 69
Newcastle's Disease 12
Pseudo-Fowlpest 12

Classifications:



External Ids:

Disease Ontology 12 DOID:2929
MeSH 42 D009521
NCIt 47 C34849
UMLS 69 C0027983

Summaries for Newcastle Disease

Disease Ontology : 12 A viral infectious disease that results_in infection in birds and humans, has material basis in Newcastle disease virus, which is transmitted_by contact with feces and urine of an infected bird, or transmitted_by fomites. The infection has symptom conjunctivitis, has symptom headache, and has symptom lacrimation in humans, and has symptom gasping, has symptom coughing, has symptom twisting of head and neck, has symptom circling, has symptom complete paralysis, has symptom watery diarrhea, and has symptom reduced egg production in birds.

MalaCards based summary : Newcastle Disease, also known as newcastle's disease, is related to influenza and avian influenza, and has symptoms including conjunctivitis, headache and lacrimation in humans. An important gene associated with Newcastle Disease is IFNB1 (Interferon Beta 1), and among its related pathways/superpathways are Innate Immune System and Cytokine Signaling in Immune system. The drugs Donepezil and Everolimus have been mentioned in the context of this disorder. Affiliated tissues include lung, eye and t cells, and related phenotypes are homeostasis/metabolism and hematopoietic system

Wikipedia : 71 Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it... more...

Related Diseases for Newcastle Disease

Diseases related to Newcastle Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 80)
id Related Disease Score Top Affiliating Genes
1 influenza 10.5
2 avian influenza 10.4
3 benign exophthalmos syndrome 10.3 IFNA1 IFNB1
4 parkinson disease type 9 10.3 IFNB1 NEU1
5 hypercementosis 10.2 IFNB1 NEU1
6 facio skeletal genital syndrome rippberger type 10.2 MMP2 MMP9
7 acute tricyclic antidepressant poisoning 10.2 MMP2 MMP9
8 noonan syndrome 4 10.2 CD36 MMP2
9 kleptomania 10.2 MMP2 MMP9
10 leukoencephalopathy palmoplantar keratoderma 10.2 MMP2 MMP9
11 turner syndrome 10.2 IFNB1 IRF3
12 thymus adenocarcinoma 10.2 MMP2 MMP9
13 spinal meninges cancer 10.2 MMP2 MMP9
14 neonatal hypoxic and ischemic brain injury 10.1 MMP2 MMP9
15 gastroduodenitis 10.1 DDX58 IFNA1 IFNB1
16 senile atrophy of choroid 10.1 MMP2 MMP9
17 bronchitis 10.1
18 tinea profunda 10.1 MMP2 MMP9
19 neonatal jaundice 10.1 IFNA1 IFNB1 MMP9
20 complex regional pain syndrome 10.1 IFNA1 IFNB1 MMP9
21 viral meningitis 10.1 MMP2 MMP9
22 lymphocytic colitis 10.1 MMP2 MMP9
23 osmotic diarrhea 10.1 DDX58 IFNB1 IRF3
24 laryngotracheitis 10.1
25 onychocytic matricoma 10.1 CD36 MMP2 MMP9
26 juvenile astrocytoma 10.1 IFNB1 MMP2 MMP9
27 laryngostenosis 10.1 CD36 MMP2 MMP9
28 adenocarcinoma in situ 10.1 MMP2 MMP9
29 hepatitis c virus 10.1 DDX58 IFNA1 IRF3
30 appendix carcinoid tumor 10.0 MMP2 MMP9
31 bardet-biedl syndrome 10.0 KLK3 MMP2 MMP9
32 corneal staphyloma 10.0 MMP2 MMP9
33 malignant pleural solitary fibrous tumor 10.0 KLK3 MMP2 MMP9
34 glucosephosphate isomerase deficiency 10.0 BAX MMP2 MMP9
35 central nervous system angiosarcoma 10.0 DDX58 IFNA1 IRF7 NEU1
36 variola minor 10.0 IRF3 IRF7
37 upper gum cancer 9.9 DDX58 IFNA1 IFNB1 IRF3
38 pancreatitis 9.9
39 mucositis 9.9
40 linear porokeratosis 9.9 MMP2 MMP9
41 adenocarcinoma 9.9
42 embryonal carcinoma 9.9 IFNA1 IFNB1 IRF3 IRF7
43 hereditary hemorrhagic telangiectasia 9.9 DDX58 IFNA1 IRF3 IRF7
44 rabies 9.8
45 encephalitis 9.8
46 stomatitis 9.8
47 glioma 9.8
48 melanoma 9.8
49 exophthalmos 9.8 DDX58 IFNA1 IFNB1 IRF3 IRF7
50 hyperimmunoglobulin syndrome 9.8 CTRL IFNA1 IFNB1 IRF3

Graphical network of the top 20 diseases related to Newcastle Disease:



Diseases related to Newcastle Disease

Symptoms & Phenotypes for Newcastle Disease

Symptoms:

12
  • conjunctivitis
  • headache
  • lacrimation in humans
  • gasping
  • coughing
  • twisting of head
  • circling
  • complete paralysis
  • watery diarrhea
  • reduced egg production in birds

UMLS symptoms related to Newcastle Disease:


discharge from eye

MGI Mouse Phenotypes related to Newcastle Disease:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 9.96 BAX CD36 DDX58 IFNB1 IRF3 IRF7
2 hematopoietic system MP:0005397 9.92 BAX CD36 DDX58 IFNB1 IRF7 MMP2
3 immune system MP:0005387 9.85 MMP2 MMP9 NEU1 UMOD BAX CD36
4 neoplasm MP:0002006 9.35 BAX DDX58 IFNB1 MMP2 MMP9
5 skeleton MP:0005390 9.17 BAX CD36 IFNB1 MMP2 MMP9 NEU1

Drugs & Therapeutics for Newcastle Disease

Drugs for Newcastle Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 887)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Donepezil Approved Phase 4,Phase 3 120014-06-4 3152
2
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1 159351-69-6 6442177
3
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 53123-88-9 5284616 6436030 46835353
4
Diclofenac Approved, Vet_approved Phase 4 15307-86-5 3033
5
Etoricoxib Approved, Investigational Phase 4 202409-33-4 123619
6
Candesartan Approved Phase 4 139481-59-7 2541
7
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 83-43-2 6741
8
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-24-8 5755
9
rituximab Approved Phase 4,Phase 3,Phase 2,Phase 1 174722-31-7 10201696
10
Paclitaxel Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 33069-62-4 36314
11
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1 1959-05-2, 59-05-2 126941
12
Zinc Approved Phase 4,Phase 3,Phase 2,Phase 1 7440-66-6 32051 23994
13
Insulin Aspart Approved Phase 4,Phase 3,Phase 2 116094-23-6 16132418
14
Heparin Approved, Investigational Phase 4,Phase 3 9005-49-6 772 46507594
15
Olaparib Approved Phase 4,Phase 3,Phase 1,Phase 2 763113-22-0 23725625
16
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 50-18-0, 6055-19-2 2907
17
Doxorubicin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 23214-92-8 31703
18
Etoposide Approved Phase 4,Phase 3,Phase 2,Phase 1 33419-42-0 36462
19
Ifosfamide Approved Phase 4,Phase 3,Phase 2,Phase 1 3778-73-2 3690
20
Mechlorethamine Approved Phase 4,Phase 3,Phase 1,Phase 2 51-75-2 4033
21
Vincristine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 2068-78-2, 57-22-7 5978
22
Adenosine Approved, Investigational Phase 4,Phase 3,Phase 2 58-61-7 60961
23
Amlodipine Approved Phase 4,Phase 3 88150-42-9 2162
24
Cyclosporine Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 79217-60-0, 59865-13-3 5284373 6435893
25
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2 50-78-2 2244
26
Ticlopidine Approved Phase 4,Phase 3 55142-85-3 5472
27
Cosyntropin Approved Phase 4 16960-16-0 16129617
28
Metformin Approved Phase 4,Phase 3,Phase 2 657-24-9 14219 4091
29
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1 51-61-6, 62-31-7 681
30
Memantine Approved, Investigational Phase 4 19982-08-2 4054
31
Pramipexole Approved, Investigational Phase 4,Phase 3 104632-26-0 59868 119570
32
Ramipril Approved Phase 4 87333-19-5 5362129
33
Telmisartan Approved, Investigational Phase 4,Phase 3 144701-48-4 65999
34
Cephalexin Approved, Vet_approved Phase 4 15686-71-2 27447
35
Nitrofurantoin Approved, Vet_approved Phase 4 67-20-9 5353830
36
Trimethoprim Approved, Vet_approved Phase 4 738-70-5 5578
37
Etanercept Approved, Investigational Phase 4,Phase 3 185243-69-0
38
Acetaminophen Approved Phase 4 103-90-2 1983
39
Acetylcysteine Approved, Investigational Phase 4 616-91-1 12035
40
Ondansetron Approved Phase 4,Phase 3 99614-02-5 4595
41
Azithromycin Approved Phase 4 83905-01-5 55185 53477736 447043
42
Adalimumab Approved Phase 4,Phase 3 331731-18-1 16219006
43
Infliximab Approved Phase 4,Phase 3 170277-31-3
44
Insulin Glargine Approved Phase 4,Phase 3 160337-95-1
45
Oxybutynin Approved, Investigational Phase 4,Phase 3 5633-20-5 4634
46
Abacavir Approved, Investigational Phase 4 136470-78-5 65140 441300
47
Cobicistat Approved Phase 4 1004316-88-4
48
Efavirenz Approved, Investigational Phase 4,Phase 3 154598-52-4 64139
49
Emtricitabine Approved, Investigational Phase 4 143491-57-0 60877
50
Lamivudine Approved, Investigational Phase 4 134678-17-4 60825

Interventional clinical trials:

(show top 50) (show all 1360)
id Name Status NCT ID Phase
1 CALM-AD Unknown status NCT00142324 Phase 4
2 Trial to Assess the Everolimus-Eluting Coronary Stent System (PROMUS Element) for Coronary Revascularization Unknown status NCT01342822 Phase 4
3 Bipolar Sealer Aquamantys Use in Total Knee Replacement Unknown status NCT01736644 Phase 4
4 Comparison of the Effect of Etoricoxib and Diclofenac on Early Morning Activity in Rheumatoid Arthritis (RA) Unknown status NCT01067430 Phase 4
5 Acute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST) Unknown status NCT00108706 Phase 4
6 A Study Comparing Photoselective Vaporization of the Prostate With the GreenLight XPS™ Laser System and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Hyperplasia Unknown status NCT01218672 Phase 4
7 Platelet-dependent Thrombosis: a Placebo-controlled Trial of Antiplatelet Therapy (Clopidogrel) Completed NCT00728156 Phase 4
8 Revival of Stem Cells in Addison's Study Completed NCT01371526 Phase 4
9 Three Year Follow up of a Randomised Controlled Trial (RCT) of an Intervention for Tobacco Dependence Among Those With a Psychotic Illness Completed NCT00350493 Phase 4
10 The Study to Treat Superficial Femoral Artery Occlusions. Completed NCT00232843 Phase 4
11 Rescue of Steroidogenic Capacity in Adrenocortical Failure Study (RADS) Completed NCT00753597 Phase 4
12 SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary Disease Completed NCT00361959 Phase 4
13 Metformin in Chronic Obstructive Pulmonary Disease Completed NCT01247870 Phase 4
14 Effect of Memantine on Functional Communication in Patients With Alzheimer's Disease Completed NCT00469456 Phase 4
15 Study of (Mirapex) Pramipexole for the Early Treatment of Parkinsons Disease (PD) Completed NCT00321854 Phase 4
16 Retreatment of Recurrent Dupuytren's Contractures Completed NCT01498640 Phase 4
17 Exploratory Muscle Biopsy Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase Alfa Completed NCT01288027 Phase 4
18 Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo. Completed NCT00153101 Phase 4
19 Comparison of Indacaterol 150 mcg Once Daily (o.d.) With Salmeterol/Fluticasone Propionate 50 mcg/500 mcg Twice Daily (b.i.d.) Completed NCT01555138 Phase 4
20 Cognitive and Cerebral Blood Flow Effects of Vitamin C Completed NCT01055418 Phase 4
21 Effects of Dietary Nitrate From Vegetable/Fruit Juice on Cerebral Blood Flow Parameters Completed NCT01169662 Phase 4
22 Antibiotic Prophylaxis for Clean Intermittent Catheterisation Completed NCT02145338 Phase 4
23 CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events Completed NCT00327418 Phase 4
24 A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors Completed NCT01331837 Phase 4
25 Scottish and Newcastle Anti-emetic Pre-treatment for Paracetamol Poisoning Study (SNAP) Completed NCT01050270 Phase 4
26 Prospective Research in Memory Clinics (PRIME) Completed NCT00297271 Phase 4
27 Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients. Completed NCT00563381 Phase 4
28 AZithromycin Against pLacebo in Exacerbations of Asthma Completed NCT01444469 Phase 4
29 The Dual Antiplatelet Therapy Study (DAPT Study) Completed NCT00977938 Phase 4
30 A Study of Tocilizumab (RoActemra/Actemra) Versus Adalimumab in Patients With Rheumatoid Arthritis Completed NCT01119859 Phase 4
31 A Long-term Safety Study of Infliximab (Remicade) Completed NCT00261976 Phase 4
32 Study of Optimal Replacement of Thyroxine in the Elderly Completed NCT01647750 Phase 4
33 Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis Completed NCT00420927 Phase 4
34 Prevention of Severe Hypoglycemia in Type 1 Diabetes Completed NCT00360984 Phase 4
35 Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis Completed NCT00629642 Phase 4
36 Renal Effect of Stribild or Other Tenofovir DF-containing Regimens Compared to Ritonavir-boosted Atazanavir Plus Abacavir/Lamivudine in Antiretroviral Treatment-naive HIV-1 Infected Adults Completed NCT02246998 Phase 4
37 Study to Assess the Effect of 24 Weeks of Treatment With Vildagliptin in Patients With Type 2 Diabetes Completed NCT01356381 Phase 4
38 The Effect of Levetiracetam (Keppra) on the Treatment of Tremor in Multiple Sclerosis Completed NCT00430599 Phase 4
39 RCT to Investigate if Prophylactic Antibiotics Prevent Further Episodes of Cellulitis (Erysipelas) of the Leg Completed NCT00552799 Phase 4
40 Macular EpiRetinal Brachytherapy Versus Lucentis® Only Treatment (MERLOT) Completed NCT01006538 Phase 4
41 HRT Versus Etidronate for Osteoporosis and Fractures in Asthmatics Receiving Glucocorticoids. Completed NCT00376662 Phase 4
42 Long-term Follow-up of Fingolimod Phase II Study Patients Completed NCT02307838 Phase 4
43 Exubera Large Simple Trial To Evaluate Long-Term Pulmonary And Cardiovascular Safety Completed NCT00359801 Phase 4
44 The Press Fit Condylar (P.F.C.) Sigma Metal-backed Versus All-poly Completed NCT00733928 Phase 4
45 Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis Completed NCT00913458 Phase 4
46 A 30 Day Study to Evaluate Efficacy and Safety of Pre-hospital vs. In-hospital Initiation of Ticagrelor Therapy in STEMI Patients Planned for Percutaneous Coronary Intervention (PCI) Completed NCT01347580 Phase 4
47 EUropean Pharmacogenetics of AntiCoagulant Therapy - Warfarin Completed NCT01119300 Phase 4
48 Extension Study Evaluating Etanercept in Ankylosing Spondylitis Completed NCT00410046 Phase 4
49 The Effect of Exercise on Blood Glucose Levels in Patients With Type 1 Diabetes: A Comparison of 3 Long-acting Insulins Completed NCT00313742 Phase 4
50 A Study to Compare the Effectiveness and Safety of Fesoterodine and Placebo in an Elderly Population of Patients Who go to the Toilet Very Frequently Due to Overactive Bladder. Completed NCT00798434 Phase 4

Search NIH Clinical Center for Newcastle Disease

Cochrane evidence based reviews: newcastle disease

Genetic Tests for Newcastle Disease

Anatomical Context for Newcastle Disease

MalaCards organs/tissues related to Newcastle Disease:

39
Lung, Eye, T Cells, Testes, Brain, Prostate, Tongue

Publications for Newcastle Disease

Articles related to Newcastle Disease:

(show top 50) (show all 651)
id Title Authors Year
1
Newcastle disease virus from domestic mink, China, 2014. ( 28061999 )
2017
2
Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies. ( 28052812 )
2017
3
Recombinant Newcastle disease virus expressing the infectious bronchitis virus S1 gene protects chickens against Newcastle disease virus and infectious bronchitis virus challenge. ( 28342665 )
2017
4
New real time and conventional RT-PCRs for updated molecular diagnosis of infectious bronchitis virus infection (IBV) in chickens in Egypt associated with frequent co-infections with avian influenza and Newcastle Disease viruses. ( 28336367 )
2017
5
Efficacy of vaccination with La Sota strain vaccine to control Newcastle disease in village chickens in Nepal. ( 27987111 )
2017
6
Construction of recombinant baculovirus vaccines for Newcastle Disease Virus and an assessment of their immunogenicity. ( 27015979 )
2016
7
Newcastle disease in Nigeria: epizootiology and current knowledge of circulating genotypes. ( 28004012 )
2016
8
Newcastle disease virus chimeras expressing the Hemagglutinin- Neuraminidase protein of mesogenic strain exhibits an enhanced anti-hepatoma efficacy. ( 27164362 )
2016
9
Viscerotropic velogenic Newcastle disease virus replication in feathers of infected chickens. ( 27051348 )
2016
10
HN protein of Newcastle disease virus sensitizes HeLa cells to TNF-I+-induced apoptosis by downregulating NF-I_B expression. ( 27294845 )
2016
11
Recombinant Newcastle disease virus (NDV/Anh-IL-2) expressing human IL-2 as a potential candidate for suppresses growth of hepatoma therapy. ( 27174862 )
2016
12
Thermal Stability Study of Five Newcastle Disease Attenuated Vaccine Strains. ( 27902907 )
2016
13
Kinetic analysis of RNA editing of Newcastle disease virus P gene in the early period of infection. ( 26982470 )
2016
14
Complete Genome Sequence of Genotype VI Newcastle Disease Viruses Isolated from Pigeons in Pakistan. ( 27540069 )
2016
15
Repeated isolation of virulent Newcastle disease viruses of sub-genotype VIId from backyard chickens in Bulgaria and Ukraine between 2002 and 2013. ( 27581808 )
2016
16
Construction and Application of Newcastle Disease Virus-Based Vector Vaccines. ( 26458839 )
2016
17
Genetic Modification of Oncolytic Newcastle Disease Virus for Cancer Therapy. ( 27009956 )
2016
18
Derivation of chicken induced pluripotent stem cells tolerant to Newcastle disease virus-induced lysis through multiple rounds of infection. ( 27919263 )
2016
19
Newcastle disease virus, rituximab, and doxorubicin combination as anti-hematological malignancy therapy. ( 27579294 )
2016
20
Expression of recombinant Newcastle disease virus F protein in Pichia pastoris and its immunogenicity using flagellin as the adjuvant. ( 27546452 )
2016
21
Identification of 2'-5'-Oligoadenylate Synthetase-Like Gene in Goose: Gene Structure, Expression Patterns, and Antiviral Activity Against Newcastle Disease Virus. ( 27576097 )
2016
22
Regulation of de novo translation of host cells by manipulation of PERK/PKR and GADD34-PP1 activity during Newcastle disease virus infection. ( 26869028 )
2016
23
Erratum to: Serological response and protection level evaluation in chickens exposed to grains coated with I2 Newcastle disease virus for effective oral vaccination of village chickens. ( 27931235 )
2016
24
Atrophy of the lymphoid organs and suppression of antibody response caused by velogenic Newcastle disease virus infection in chickens. ( 27645826 )
2016
25
Identification and functional analysis of phosphorylation in Newcastle disease virus phosphoprotein. ( 27160999 )
2016
26
Generation of Newcastle Disease Virus (NDV) Recombinants Expressing the Infectious Laryngotracheitis Virus (ILTV) Glycoprotein gB or gD as Dual Vaccines. ( 27076292 )
2016
27
Complete Genome Sequence of a Virulent Newcastle Disease Virus Strain Isolated from a Clinically Healthy Duck (Anas platyrhynchos domesticus) in Pakistan. ( 27469959 )
2016
28
May Newly Defined Genotypes XVII and XVIII of Newcastle Disease Virus in Poultry from West and Central Africa Be Considered a Single Genotype (XVII)? ( 27578155 )
2016
29
Design, Synthesis and Biological Evaluation of Novel Phosphorylated Abacavir Derivatives as Antiviral Agents Against Newcastle Disease Virus Infection in Chicken. ( 27142273 )
2016
30
IgA response and protection following nasal vaccination of chickens with Newcastle disease virus DNA vaccine nanoencapsulated with Ag@SiO2 hollow nanoparticles. ( 27170532 )
2016
31
Reply to "May Newly Defined Subgenotypes Va and Vb of Newcastle Disease Virus in Poultry Be Considered Two Different Genotypes?". ( 27458270 )
2016
32
CD55 is a key complement regulatory protein that counteracts complement-mediated inactivation of Newcastle disease virus. ( 27153814 )
2016
33
Identification of novel Newcastle disease virus sub-genotype VII-(j) based on the fusion protein. ( 28004254 )
2016
34
Chimeric rabies glycoprotein with a transmembrane domain and cytoplasmic tail from Newcastle disease virus fusion protein incorporates into the Newcastle disease virion at reduced levels. ( 27515260 )
2016
35
Complete Genome Sequences of Two Subgenotype 1b Newcastle Disease Viruses Isolated from Sansui Sheldrake Ducks in Guizhou, China. ( 27932647 )
2016
36
Recombinant Newcastle disease virus expressing P53 demonstrates promising antitumor efficiency in hepatoma model. ( 27465066 )
2016
37
Molecular characterization of genotype XIIIb Newcastle disease virus from central India during 2006-2012: Evidence of its panzootic potential. ( 27497893 )
2016
38
Recombinant Newcastle disease virus expressing H9 HA protects chickens against heterologous avian influenza H9N2 virus challenge. ( 27102817 )
2016
39
Newcastle disease virus-vectored West Nile fever vaccine is immunogenic in mammals and poultry. ( 27342050 )
2016
40
Susceptibility of primary chicken intestinal epithelial cells for low pathogenic avian influenza virus and velogenic viscerotropic Newcastle disease virus. ( 27596739 )
2016
41
May Newly Defined Subgenotypes Va and Vb of Newcastle Disease Virus in Poultry Be Considered Two Different Genotypes? ( 27458269 )
2016
42
An improved reverse genetics system for Newcastle disease virus genotype VII. ( 27933564 )
2016
43
Re-evaluation the immune efficacy of Newcastle disease virus vaccine in commercial laying chickens. ( 28043009 )
2016
44
Synthesis and Antiviral Activity of Novel Phosphorylated Derivatives of Didanosine Against Newcastle Disease Virus in Chicken. ( 27128998 )
2016
45
Newcastle disease virus induces stable formation of bona fide stress granules to facilitate viral replication through manipulating host protein translation. ( 28011649 )
2016
46
Genome Sequence of a Virulent Genotype III Newcastle Disease Virus Isolated from Laying Ducks in China. ( 28034854 )
2016
47
Improved immunogenicity of Newcastle disease virus inactivated vaccine following DNA vaccination using Newcastle disease virus hemagglutinin-neuraminidase and fusion protein genes. ( 27051336 )
2016
48
Presence of Vaccine-Derived Newcastle Disease Viruses in Wild Birds. ( 27626272 )
2016
49
Simultaneous mutation of G275A and P276A in the matrix protein of Newcastle disease virus decreases virus replication and budding. ( 27600544 )
2016
50
Reply to "May Newly Defined Genotypes XVII and XVIII of Newcastle Disease Virus in Poultry from West and Central Africa Be Considered a Single Genotype (XVII)?". ( 27578156 )
2016

Variations for Newcastle Disease

Expression for Newcastle Disease

Search GEO for disease gene expression data for Newcastle Disease.

Pathways for Newcastle Disease

Pathways related to Newcastle Disease according to GeneCards Suite gene sharing:

(show all 23)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.82 CD36 DDX58 IFNA1 IFNB1 IRF3 IRF7
2
Show member pathways
12.87 CD36 DDX58 IFNA1 IFNB1 IRF3 IRF7
3
Show member pathways
12.77 CD36 IFNA1 IFNB1 IRF3 IRF7
4
Show member pathways
12.58 DDX58 IFNA1 IFNB1 IRF3 IRF7
5
Show member pathways
12.5 DDX58 IFNA1 IFNB1 IRF3 IRF7
6 12.47 BAX KLK3 MMP2 MMP9
7 12.32 DDX58 IFNA1 IRF3 IRF7
8
Show member pathways
12.28 BAX DDX58 IFNA1 IFNB1 IRF3 IRF7
9
Show member pathways
12.21 DDX58 IFNA1 IFNB1 IRF3 IRF7
10
Show member pathways
12.06 CD36 IFNB1 IRF3 IRF7
11 12.04 BAX IFNA1 IFNB1
12 12 BAX MMP2 MMP9
13 11.93 IFNA1 IFNB1 IRF3 IRF7
14
Show member pathways
11.88 IFNA1 IFNB1 IRF3 IRF7
15 11.79 CD36 MMP2 MMP9
16 11.77 KLK3 MMP2 MMP9
17 11.47 KLK3 MMP2 MMP9
18 11.14 DDX58 IFNA1 IFNB1 IRF3 IRF7
19 11.12 CD36 MMP2 MMP9
20 11.01 MMP2 MMP9
21 11.01 MMP2 MMP9
22 10.91 KLK3 MMP2
23
Show member pathways
10.79 DDX58 IRF3 IRF7

GO Terms for Newcastle Disease

Cellular components related to Newcastle Disease according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.5 IFNA1 IFNB1 KLK3 MMP2 MMP9 NEU1
2 extracellular space GO:0005615 9.17 CD36 CTRL IFNA1 IFNB1 KLK3 MMP2

Biological processes related to Newcastle Disease according to GeneCards Suite gene sharing:

(show all 22)
id Name GO ID Score Top Affiliating Genes
1 innate immune response GO:0045087 9.91 DDX58 IFNA1 IRF3 IRF7
2 viral process GO:0016032 9.87 BAX DDX58 IRF3 IRF7
3 response to virus GO:0009615 9.65 DDX58 IFNB1 IRF7
4 positive regulation of release of cytochrome c from mitochondria GO:0090200 9.6 BAX MMP9
5 regulation of type I interferon-mediated signaling pathway GO:0060338 9.59 IFNA1 IFNB1
6 TRIF-dependent toll-like receptor signaling pathway GO:0035666 9.58 IRF3 IRF7
7 endodermal cell differentiation GO:0035987 9.58 MMP2 MMP9
8 T cell activation involved in immune response GO:0002286 9.56 IFNA1 IFNB1
9 type I interferon signaling pathway GO:0060337 9.56 IFNA1 IFNB1 IRF3 IRF7
10 positive regulation of peptidyl-serine phosphorylation of STAT protein GO:0033141 9.55 IFNA1 IFNB1
11 positive regulation of innate immune response GO:0045089 9.54 IFNB1 MMP2
12 natural killer cell activation involved in immune response GO:0002323 9.52 IFNA1 IFNB1
13 regulation of type I interferon production GO:0032479 9.51 IRF3 IRF7
14 positive regulation of interferon-beta production GO:0032728 9.5 DDX58 IRF3 IRF7
15 positive regulation of vascular smooth muscle cell proliferation GO:1904707 9.49 MMP2 MMP9
16 positive regulation of type I interferon-mediated signaling pathway GO:0060340 9.46 IRF3 IRF7
17 cellular response to dsRNA GO:0071359 9.43 IFNB1 IRF3
18 type I interferon biosynthetic process GO:0045351 9.4 IRF3 IRF7
19 MDA-5 signaling pathway GO:0039530 9.37 IRF3 IRF7
20 defense response to virus GO:0051607 9.35 DDX58 IFNA1 IFNB1 IRF3 IRF7
21 positive regulation of interferon-alpha production GO:0032727 9.33 DDX58 IRF3 IRF7
22 response to exogenous dsRNA GO:0043330 8.92 DDX58 IFNA1 IFNB1 IRF3

Molecular functions related to Newcastle Disease according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 hydrolase activity GO:0016787 9.8 CTRL DDX58 KLK3 MMP2 MMP9 NEU1
2 cytokine receptor binding GO:0005126 9.26 IFNA1 IFNB1
3 type I interferon receptor binding GO:0005132 9.16 IFNA1 IFNB1
4 regulatory region DNA binding GO:0000975 8.96 IRF3 IRF7
5 serine-type endopeptidase activity GO:0004252 8.92 CTRL KLK3 MMP2 MMP9

Sources for Newcastle Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....